TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Clinical trial NCT02083783 · COMPLETED
Trial details
- NCT number
- NCT02083783
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-10-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.